China Pharmaceutical Technology Company MICOT Raised ¥115 Million in Series Pre-A Round Funding

0
China Pharmaceutical Technology Company MICOT Raised ¥115 Million in Series Pre-A Round Funding
China Pharmaceutical Technology Company MICOT Raised ¥115 Million in Series Pre-A Round Funding

China Pharmaceutical Technology Company MICOT Raised ¥115 million in series pre-A round funding led by Norther Light Venture Capital, and followed by Tasly Holding Group, DT Capital Partners, and JunYing Growth Fund. The investment will be mainly used in clinical research of multiple drugs.

MICOT specializes in the research and development of new drugs for fatal major diseases such as cardiovascular and metabolic diseases, covering five major diseases such as ischemic heart disease, stroke, antithrombotic, nervous system injury, degenerative change and diabetes.

South Africa Today


Read more at VolaNews

Disclaimer: The views of authors published on South Africa Today are their own and do not necessarily represent the views of South Africa Today. By viewing, visiting, using, or interacting with SouthAfricaToday.net, you are agreeing to all the provisions of the Terms of Use Policy and the Privacy Policy.